Sarcopenia: Current Concepts
Top Cited Papers
Open Access
- 1 December 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journals of Gerontology: Series A
- Vol. 55 (12), M716-M724
- https://doi.org/10.1093/gerona/55.12.m716
Abstract
Sarcopenia, the loss of muscle mass and strength with age, is becoming recognized as a major cause of disability and morbidity in the elderly population. Sarcopenia is part of normal aging and does not require a disease to occur, although muscle wasting is accelerated by chronic diseases. Sarcopenia is thought to have multiple causes, although the relative importance of each is not clear. Neurological, metabolic, hormonal, nutritional, and physical-activity–related changes with age are likely to contribute to the loss of muscle mass. In this review, we discuss current concepts of the pathogenesis, treatment, and prevention of sarcopenia.Keywords
This publication has 87 references indexed in Scilit:
- Continuation of Growth Hormone (GH) Replacement in GH-Deficient Patients during Transition from Childhood to Adulthood: A Two-Year Placebo-Controlled StudyJournal of Clinical Endocrinology & Metabolism, 2000
- Changes in muscle strength, muscle fibre size and myofibrillar gene expression after immobilization and retraining in humansThe Journal of Physiology, 2000
- Serial Changes in Body Composition Throughout Adulthood and Their Relationships to Changes in Lipid and Lipoprotein LevelsArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- The Relationship between Growth Hormone Kinetics and Sarcopenia in Postmenopausal Women: The Role of Fat Mass and LeptinJournal of Clinical Endocrinology & Metabolism, 1998
- The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal MenNew England Journal of Medicine, 1996
- Protein metabolism in rheumatoid arthritis and aging. Effects of muscle strength training and tumor necrosis factor αArthritis & Rheumatism, 1996
- The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.Journal of Clinical Investigation, 1995
- 17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism.Journal of Clinical Investigation, 1994
- Interleukin-1, interleukin-6, and tumor necrosis factor α are produced in the mouse uterus during the estrous cycle and are induced by estrogen and progesteroneDevelopmental Biology, 1992
- Reduced Rate of Energy Expenditure as a Risk Factor for Body-Weight GainNew England Journal of Medicine, 1988